These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 28390291

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.
    Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, Çakar M, Egido J, Altun B, Yenicesu M, Blanco-Colio LM, Carrero JJ.
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):785-92. PubMed ID: 21330486
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Serum sTWEAK levels in chronic periodontitis and type 2 diabetes mellitus.
    Acharya AB, Chandrashekar A, Acharya S, Shettar L, Thakur S.
    Diabetes Metab Syndr; 2019 Apr; 13(2):1609-1613. PubMed ID: 31336529
    [Abstract] [Full Text] [Related]

  • 29. Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes.
    Gonçalves I, Edsfeldt A, Colhoun HM, Shore AC, Palombo C, Natali A, Fredrikson GN, Björkbacka H, Wigren M, Bengtsson E, Östling G, Aizawa K, Casanova F, Persson M, Gooding K, Gates P, Khan F, Looker HC, Adams F, Belch J, Pinnola S, Venturi E, Kozakova M, Gan LM, Schnecke V, Nilsson J, SUMMIT consortium.
    BMC Cardiovasc Disord; 2016 Sep 05; 16(1):171. PubMed ID: 27596252
    [Abstract] [Full Text] [Related]

  • 30. Inverse Relationship between Plasma Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Carotid Intima-Media Thickness among Patients Undergoing Hemodialysis and Peritoneal Dialysis.
    Shi X, Qiu B, Shen H, Feng S, Fu J.
    Cardiorenal Med; 2020 Sep 05; 10(3):137-144. PubMed ID: 32126565
    [Abstract] [Full Text] [Related]

  • 31. Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study.
    Abajo M, Betriu À, Arroyo D, Gracia M, Del Pino MD, Martínez I, Valdivielso JM, Fernández E, Investigators of the NEFRONA study.
    Nephrol Dial Transplant; 2017 Nov 01; 32(11):1882-1891. PubMed ID: 27566835
    [Abstract] [Full Text] [Related]

  • 32. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study.
    Betriu A, Martinez-Alonso M, Arcidiacono MV, Cannata-Andia J, Pascual J, Valdivielso JM, Fernández E, Investigators from the NEFRONA Study.
    Nephrol Dial Transplant; 2014 Jul 01; 29(7):1415-22. PubMed ID: 24586070
    [Abstract] [Full Text] [Related]

  • 33. Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation.
    Lozano-Bartolomé J, Llauradó G, Rodriguez MM, Fernandez-Real JM, Garcia-Fontgivell JF, Puig J, Maymó-Masip E, Vendrell J, Chacón MR.
    Int J Obes (Lond); 2016 Sep 01; 40(9):1337-45. PubMed ID: 27121253
    [Abstract] [Full Text] [Related]

  • 34. Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio.
    Moreno JA, Dejouvencel T, Labreuche J, Smadja DM, Dussiot M, Martin-Ventura JL, Egido J, Gaussem P, Emmerich J, Michel JB, Blanco-Colio LM, Meilhac O.
    Arterioscler Thromb Vasc Biol; 2010 Jun 01; 30(6):1253-62. PubMed ID: 20299688
    [Abstract] [Full Text] [Related]

  • 35. Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.
    Carrero JJ, Ortiz A, Qureshi AR, Martín-Ventura JL, Bárány P, Heimbürger O, Marrón B, Metry G, Snaedal S, Lindholm B, Egido J, Stenvinkel P, Blanco-Colio LM.
    Clin J Am Soc Nephrol; 2009 Jan 01; 4(1):110-8. PubMed ID: 18945991
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of soluble TNF-like weak inducer of apoptosis (sTWEAK) levels to predict preeclampsia in early weeks of pregnancy.
    Shahid S, Khalid E, Fatima SS, Khan GM.
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar 01; 234():165-170. PubMed ID: 30708268
    [Abstract] [Full Text] [Related]

  • 37. The significance of diminished sTWEAK and P-selectin content in platelets of patients with pulmonary arterial hypertension.
    Kazimierczyk R, Błaszczak P, Kowal K, Jasiewicz M, Knapp M, Szpakowicz A, Ptaszyńska-Kopczyńska K, Sobkowicz B, Waszkiewicz E, Grzywna R, Musial WJ, Kamiński KA.
    Cytokine; 2018 Jul 01; 107():52-58. PubMed ID: 29203267
    [Abstract] [Full Text] [Related]

  • 38. Soluble TWEAK levels are independently associated with coronary artery disease severity in patients with stage 2-3 kidney disease.
    Azak A, Akdoğan MF, Denizli N, Huddam B, Koçak G, Gücün M, Tatlısu MA, Demirci R, Yılmaz B, Dikeç M, Bakırtaş M, Akdağ I, Duranay M.
    Int Urol Nephrol; 2014 Feb 01; 46(2):411-5. PubMed ID: 24043442
    [Abstract] [Full Text] [Related]

  • 39. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease.
    Icli A, Cure MC, Cure E, Arslan S, Unal M, Sakiz D, Ozucan M, Toker A, Turkmen K, Kucuk A.
    Acta Medica (Hradec Kralove); 2018 Feb 01; 61(3):86-92. PubMed ID: 30543512
    [Abstract] [Full Text] [Related]

  • 40. Serum and tissue endothelin-1 are independent from intima-media thickness of peripheral arteries in patients with chronic kidney disease.
    Nezami N, Sepehrvand N, Mirchi M, Salari B, Shokouhi B, Ghojazadeh M, Naghavi-Behzad M, Ghorashi S, Mirzaie F, Noshad H, Zomorrodi A, Gharedaghi A, Babapoor-Farrokhran S, Mirbagheri S, Tarzamni MK.
    Vascular; 2015 Aug 01; 23(4):382-90. PubMed ID: 25245046
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.